Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹1,360.90
Market cap: ₹1,944 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 44.4×Sector 50.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Financial Results 2 Acquisition 2 Product Launch 1 Capital Structure Change 1 Business Update 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

16 Sep 2026 20:52 IST BSE

Board Meeting Outcome

Fredun Pharmaceuticals Board Meeting Outcome

Fredun Pharmaceuticals allotted 2,71,200 equity shares following the conversion of 90,400 warrants. The board approved the issuance, raising Rs 11.3 Crore in total consideration.

Value: ₹11.30 Cr

Read the filing ↗